RESEARCH & DISCOVERIES

Current Areas of Study

Prevention of Autoimmune Myocarditis from Cancer Immunotherapy

Use novel precision medicine approaches such as single-cell multi-omics to discover novel biomarkers and therapeutic drug targets to treat/prevent ICI myocarditis

Experimentally validate novel targets with animal and cell modeling

Discover and target putative antigens driving T-cell activation

Pathological Mechanisms of Cardiac Autoimmunity

Use single-cell multi-omics and experimental validation to uncover disease biomarkers in other cardiac inflammatory diseases, such as cardiac sarcoidosis and heart failure

Disease Biomarker Discovery

Employ cutting-edge bioinformatics techniques to integrate single-cell multi-omics data to uncover biological insights in various cardiac inflammatory diseases

Explore novel applications of existing bioinformatics techniques to improve accessibility for the biomedical research community

Partner With Us

Support from philanthropic partners helps accelerate our mission to make cancer therapy safer for patients worldwide. Contributions directly enable translational research efforts in cardiac inflammation research including patient biobanking, advanced multi-omics profiling, development of human iPSC disease models, and early-stage therapeutic discovery projects. Philanthropy also supports the next generation of clinician-scientists working at the intersection of cardiology, oncology, and immunology, while helping expand patient-centered clinical and research programs at Stanford.

Contact: hanzhu@stanford.edu